Anthony Caggiano's most recent trade in Cognition Therapeutics Inc was a trade of 5,296 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Feb. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. | 15 Feb 2025 | 5,296 | 418,554 | - | 0.6 | 3,125 | Common Stock |
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 295,000 | 423,850 | - | 0 | Common Stock | |
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 03 Feb 2025 | 12,779 | 128,850 | - | 0.7 | 8,511 | Common Stock |
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Cognition Therapeutics Inc | Caggiano Anthony | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 60,000 | 141,629 | - | 0 | Common Stock | |
| Cognition Therapeutics Inc | Caggiano Anthony | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.29 per share. | 03 Feb 2024 | 12,777 | 81,629 | - | 2.3 | 29,259 | Common Stock |
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 94,406 | 94,406 | - | - | Stock Option (Right to Buy) | |
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 94,406 | 94,406 | - | 0 | Common Stock | |
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Anthony Caggiano | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 161,676 | 161,676 | - | - | Stock Option (right to buy) |